Azolidina derived Compounds, Pharmaceutical composition useful for treating Metabolic Disorders mediated by insulin resistance or hyperglycemia, urinary incontinence and inflammations.

摘要

The present Invention relates to compounds of the formula I with the structure where a, X, y, Z, W, R1, R2, R3, R4,R5 and R6 are as defined above or a pharmaceutically acceptable Salt thereof.Which are appropriate in the Treatment or inhibition of Metabolic Disorders related to insulin resistance or hyperglycemia (typically associated with obesdidad or intoleranceThe arteriosclerosis Glucose), gastrointestinal disorders, neurogenetic inflammation, glaucoma,Ocular hypertension and frequent urination and are particularly appropriate in the Treatment or inhibition of Type II diabetes.